Cannabix Technologies Enters Contract Manufacturing Agreement with Price Industries for BreathLogix Devices
Cannabix Technologies (BLOZF) has selected Price Industries Ltd. as the contract manufacturer for its BreathLogix alcohol screening device product line. Price Electronics, with its 28,000 square foot facility in Winnipeg, holds ISO 13485, ISO9001, and IPC certifications, offering scalable manufacturing capabilities.
The company's BreathLogix "Workplace Series" device recently received National Highway Traffic Safety Association approval and was added to the U.S. Federal Register Conforming Products List for breath alcohol screen devices. Additionally, Cannabix secured an exclusive distribution agreement with Breathalyser Sales & Service Pty Ltd. for Australia, New Zealand, and Pacific Islands markets.
The company is also in discussions with U.S. and Canadian manufacturers regarding its Marijuana Breath Testing technology, including its Breath Collection Unit, Breath Cartridge technology, and disposable parts.
Cannabix Technologies (BLOZF) ha scelto Price Industries Ltd. come produttore a contratto per la sua linea di dispositivi di screening alcolico BreathLogix. Price Electronics, con la sua struttura di 28.000 piedi quadrati a Winnipeg, possiede le certificazioni ISO 13485, ISO9001 e IPC, offrendo capacità produttive scalabili.
Il dispositivo "Workplace Series" di BreathLogix ha recentemente ricevuto l'approvazione dalla National Highway Traffic Safety Association ed è stato inserito nella lista dei prodotti conformi del Registro Federale degli Stati Uniti per i dispositivi di screening del respiro per alcol. Inoltre, Cannabix ha ottenuto un accordo di distribuzione esclusiva con Breathalyser Sales & Service Pty Ltd. per i mercati di Australia, Nuova Zelanda e Isole del Pacifico.
L'azienda è anche in trattative con produttori statunitensi e canadesi riguardo alla sua tecnologia per il test del respiro per marijuana, inclusi l'unità di raccolta del respiro, la tecnologia delle cartucce per il respiro e le parti usa e getta.
Cannabix Technologies (BLOZF) ha seleccionado a Price Industries Ltd. como fabricante por contrato para su línea de productos de dispositivos de detección de alcohol BreathLogix. Price Electronics, con su instalación de 28,000 pies cuadrados en Winnipeg, cuenta con certificaciones ISO 13485, ISO9001 e IPC, ofreciendo capacidades de fabricación escalables.
El dispositivo "Workplace Series" de BreathLogix recibió recientemente la aprobación de la National Highway Traffic Safety Association y fue añadido a la Lista de Productos Conformes del Registro Federal de EE.UU. para dispositivos de detección de alcohol en el aliento. Además, Cannabix aseguró un acuerdo de distribución exclusiva con Breathalyser Sales & Service Pty Ltd. para los mercados de Australia, Nueva Zelanda y las Islas del Pacífico.
La compañía también está en conversaciones con fabricantes de EE.UU. y Canadá sobre su tecnología de prueba de aliento para marihuana, incluyendo su Unidad de Recolección de Aliento, tecnología de cartuchos de aliento y partes desechables.
Cannabix Technologies (BLOZF)는 BreathLogix 알코올 측정기 제품 라인의 계약 제조업체로 Price Industries Ltd.를 선정했습니다. 위니펙에 위치한 28,000평방피트 규모의 시설을 보유한 Price Electronics는 ISO 13485, ISO9001, IPC 인증을 획득하여 확장 가능한 제조 역량을 제공합니다.
회사의 BreathLogix "Workplace Series" 장치는 최근 국가고속도로교통안전국(NHTSA) 승인을 받았으며, 미국 연방 등록부의 호흡 알코올 측정기 적합 제품 목록에 등재되었습니다. 또한 Cannabix는 호주, 뉴질랜드, 태평양 제도 시장을 대상으로 Breathalyser Sales & Service Pty Ltd.와 독점 유통 계약을 체결했습니다.
회사는 또한 미국 및 캐나다 제조업체들과 마리화나 호흡 검사 기술, 호흡 수집 장치, 호흡 카트리지 기술 및 일회용 부품에 관한 논의를 진행 중입니다.
Cannabix Technologies (BLOZF) a choisi Price Industries Ltd. comme fabricant sous contrat pour sa gamme d'appareils de dépistage d'alcool BreathLogix. Price Electronics, avec son installation de 28 000 pieds carrés à Winnipeg, détient les certifications ISO 13485, ISO9001 et IPC, offrant des capacités de fabrication évolutives.
L'appareil "Workplace Series" de BreathLogix a récemment obtenu l'approbation de la National Highway Traffic Safety Association et a été ajouté à la liste des produits conformes du registre fédéral américain pour les dispositifs de dépistage d'alcool dans l'haleine. De plus, Cannabix a conclu un accord de distribution exclusif avec Breathalyser Sales & Service Pty Ltd. pour les marchés d'Australie, de Nouvelle-Zélande et des îles du Pacifique.
L'entreprise est également en discussion avec des fabricants américains et canadiens concernant sa technologie de test de l'haleine pour la marijuana, incluant son unité de collecte de souffle, la technologie des cartouches d'haleine et les pièces jetables.
Cannabix Technologies (BLOZF) hat Price Industries Ltd. als Vertragshersteller für seine BreathLogix-Alkohol-Screening-Geräte ausgewählt. Price Electronics verfügt über eine 28.000 Quadratfuß große Anlage in Winnipeg und besitzt die Zertifizierungen ISO 13485, ISO9001 und IPC, wodurch skalierbare Fertigungskapazitäten geboten werden.
Das BreathLogix-Gerät der "Workplace Series" erhielt kürzlich die Zulassung der National Highway Traffic Safety Association und wurde in die Liste konformer Produkte des US-Bundesregisters für Atemalkohol-Screening-Geräte aufgenommen. Zudem sicherte sich Cannabix einen exklusiven Vertriebsvertrag mit Breathalyser Sales & Service Pty Ltd. für die Märkte Australien, Neuseeland und Pazifische Inseln.
Das Unternehmen befindet sich außerdem in Gesprächen mit Herstellern aus den USA und Kanada bezüglich seiner Technologie für Marihuana-Atemtests, einschließlich der Atemsammeleinheit, der Atemkartuschentechnologie und Einwegteilen.
- Secured contract manufacturing agreement with ISO-certified Price Industries
- Obtained NHTSA approval for BreathLogix Workplace Series device
- Established exclusive distribution agreement for Australia, New Zealand, and Pacific Islands markets
- None.
Cannabix has developed an autonomous alcohol breathalyzer screening device for employers and a range of industries and safety settings
VANCOUVER, British Columbia, May 29, 2025 (GLOBE NEWSWIRE) -- Cannabix Technologies Inc. (CSE: BLO) (OTC PINK: BLOZF) (Frankfurt: 8CT) (the “Company or Cannabix”) developer of marijuana and alcohol breath devices is pleased to report that it has selected Price Industries Ltd. (“Price Electronics”) as contract manufacture for its BreathLogix alcohol screening device product line. Price Electronics is a well-established contract manufacturer with ISO 13485 (medical devices qualifications), ISO9001 and IPC certifications. Price Electronics has a 28,000 square foot manufacturing facility located in Winnipeg, MB, set-up to cost-effectively support a full range of production volumes and product technologies with scalability.
The Company has been working with Price Electronics for several months to qualify and establish manufacturing plans. Recently the BreathLogix “Workplace Series” device was approved by National Highway Traffic Safety Association (in the United States) to be added to the U.S. Federal Register Conforming Products List (CPL) for breath alcohol screen devices. In addition, the Company recently entered into an exclusive distribution and sales agreement with Breathalyser Sales & Service Pty Ltd., for Australia, New Zealand and the Pacific Islands.
The Company also reports it is in active discussions with U.S. and Canadian based manufacturers for its Marijuana Breath Testing (“MBT”) technology, including its Breath Collection Unit (BCU), Breath Cartridge technology (BC) and disposable parts.
About Cannabix Technologies Inc.
Cannabix Technologies Inc. is a developer of marijuana and alcohol breath technologies for workplaces, law enforcement and other settings. Breath testing for delta-9 THC (the primary psychoactive ingredient in cannabis) focuses on recent marijuana use. Cannabix is the developer of the BreathLogix autonomous alcohol screening device for organizations who strive to improve alcohol safety and monitoring.
We seek Safe Harbor.
On behalf of the Board of Directors
“Rav Mlait”
CEO
Cannabix Technologies Inc.
For further information, contact the Company at info@cannabixtechnologies.com
The CSE has not reviewed and does not accept responsibility for the adequacy or accuracy of this release.
Cautionary Statement Regarding Forward-Looking Statements
This news release contains certain "forward-looking statements" within the meaning of such statements under applicable securities law. Forward-looking statements are frequently characterized by words such as "anticipates," "plan," "continue," "expect," "project," "intend," "believe," "anticipate," "estimate," "may," "will," "potential," "proposed," "positioned" and other similar words, or statements that certain events or conditions "may" or "will" occur. Forward-looking statements in this news release include, but are not limited to, statements relating to: certification of devices, acceptance of devices by international regulators, the achievement of any or all of the goals and aims of the distribution and sales agreement with any third-party companies; positive developments with contract manufacturers; the completion of pre-validation or validation testing; final development of a commercial or prototype product(s); the successful trial or pilot of company technologies; the commercialization of the Company's products; the negotiation and potential entry into additional agreements with distributors and or contract manufacturers; and the completion of future financings. There are numerous risks and uncertainties that could cause actual results and the Company’s plans and objectives to differ materially from those expressed in the forward-looking information. Important factors that could cause actual results to differ materially from those expressed in the forward-looking information include (but are note limited to): adverse market conditions; risks regarding protection of proprietary technology; the ability of the Company to complete future financings; the ability of the Company to develop and market its future product; risks regarding government regulation, managing and maintaining growth, the effect of adverse publicity, litigation, competition; that the Company’s development of cannabis and alcohol breathalyzer technologies will provide any benefit to the Company; there is no assurance that any proposed new products will be built, will be successful in beta testing or clinical trials; there is no assurance that the Company will enter into any partnerships to advance any of its corporate initiatives or technologies; there is no assurance that any “patent pending” or “provisional patents” technologies licensed by the Company or owned by the Company will receive patent status by regulatory authorities; the Company is not currently selling breathalyzers and there is no assurance that the Company ever will; and other factors beyond the control of the Company. Actual results and future events could differ materially from those anticipated in such information. These and all subsequent written and oral forward-looking information are based on estimates and opinions of management on the dates they are made and are expressly qualified in their entirety by this notice. Except as required by law, the Company does not intend to update these forward-looking statements.
FAQ
What manufacturing agreement did Cannabix Technologies (BLOZF) announce in May 2025?
What regulatory approval did Cannabix's BreathLogix Workplace Series device receive?
Which markets are covered in Cannabix's distribution agreement with Breathalyser Sales & Service?
What other products is Cannabix Technologies developing besides the BreathLogix alcohol screening device?
